Navigation Links
Intrexon Establishes "Living Arts" Company, BioPop, to Create Consumer Products Inspired by Nature and Made Possible through Science
Date:10/2/2013

GERMANTOWN, Md. and CARLSBAD, Calif., Oct. 2, 2013 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today the formation of a new "Living Arts" subsidiary called Biological & Popular Culture, Inc. (BioPop).

BioPop's team of innovative scientists and creative designers, enabled by the synthetic biology engineering technology of Intrexon, aims to create new bio-diverse products like those found in nature. The company plans to utilize the promise of synthetic biology in the field of fine and decorative arts, accessories, toys and unique novelties.  The embedded concept is "living art."

To accelerate development of new concepts Intrexon acquired a controlling equity stake in Yonder Biology, now renamed BioPop, although its principals remain significant equity owners.  Yonder's co-founder, Andy Bass, has been named BioPop's Chief Executive Officer.

"BioPop will use living organisms as bio-palettes that live, grow and respond to stimuli," Bass said.  "Imagine an art piece that 'paints' itself; a living, renewable ambient light source that operates on sunlight, water and nutrients, instead of batteries or electricity. We'll use the same technology to create toys that inspire children through novel uses of nature – combining innovation, entertainment and imagination."

"BioPop aims to evolve the traditional biotechnology industry paradigm that focuses on healthcare and therapeutics.  We are transforming biotechnology to exist in people's everyday lives.  The consumer market is large with diverse interests that will play a vibrant role in biotech's future," Bass concluded.

Andy and his team were the creators of Dino Pet, the world's first living, bioluminescent pet made from
'/>"/>

SOURCE Intrexon Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Intrexon and Rentokil Enter into Research and Development Agreement to Explore a New Generation of Highly-Effective, Sustainable Pest Controls
2. Intrexon Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option by Underwriters
3. Intrexon Prices Initial Public Offering
4. Intrexon Announces Filing of Registration Statement For Proposed Initial Public Offering
5. Intrexon Organizes Around New Synthetic Biology Markets
6. Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
7. Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
8. Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases
9. ThromboGenics Establishes Level 1 ADR Program for US Investors
10. Pittcon Establishes a Collaborative Program Resource Team for 2014
11. Alacrita Establishes U.S. Headquarters in Boston Area
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)...   Decision Resources Group finds that ... are its oral administration, alternative mechanism of action, ... rheumatologists. Otezla was the first oral therapy specifically ... psoriatic arthritis in the United States ... conventional oral treatments including disease-modifying antirheumatic drugs (DMARDs), ...
(Date:7/1/2015)... July 1, 2015   Neuraltus Pharmaceuticals, Inc. ... of groundbreaking drugs to treat neurodegenerative diseases such ... Robert G. Miller , M.D., Director of the ... California Pacific Medical Center in San Francisco, has been ... $1.5 million to help fund a Phase 2 ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan ... lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s Startup ... prizes of US$15,000 and a period of expert mentorship from a senior industry figure ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... pathogen transmission. CTI’ new Medical Joysticks have an impermeable molecular barrier protection ... an operator control device that will increase healthcare worker safety and reduce financial ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2
... Brinks Hofer Gilson & Lione, one of,the largest ... to announce that Meredith Martin Addy has been named ... practice areas by Law & Politics,magazine., Intellectual property ... However, in fourteen years of practice, Ms. Addy is,among ...
... ST. LOUIS, Feb. 19 Sigma-Aldrich(R) (Nasdaq:,SIAL) is ... joined,Sigma-Aldrich as Vice President of Global Marketing for ... responsible for our strategic,and commercial marketing efforts to ... launch of innovative products into the life,science market. ...
... 19 Campbell Alliance, the leading,management consulting ... today announced that executives from its Brand ... the 4th Annual Forum on Early,Stage Product ... hosted by the Center for Business Intelligence,(CBI). ...
Cached Biology Technology:Meredith Martin Addy Named One of Top 10 Illinois 'Super Lawyers' for 2008 2Sigma-Aldrich Names Helge Bastian New VP of Global Marketing for Research Biotech 2Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBI's Early Commercialization Conference 2Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBI's Early Commercialization Conference 3Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBI's Early Commercialization Conference 4
(Date:6/24/2015)... , June 24, 2015 The biologics safety ... major drivers for the market include growth of the ... new drug launches. Over the years, the number of ... 2001 and 2010, the FDA approved 225 drug applications ... WIPO, Europe accounted for 3,822 ...
(Date:6/23/2015)... , June 23, 2015   MedNet ... that supports the entire spectrum of clinical research, ... ™ , the company,s intuitive, flexible ... awarded a Silver 2015 Stevie® Award by the ... Products & Services Website category.  The American Business ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... market announces that its Wocket® smart wallet will be the ... scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive one ... Inc.,s CEO Gino Pereira will be discussing its ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... use of a robot to assist with the most ... patient,s risk of developing a rare but serious complication, ... edition of the Journal of Robotic Surgery. ... School at Houston statistically analyzed operative times, length of ...
... geneticist at The University of Texas Health Science Center at ... in the hopes of finding out why blood pressure often ... principal investigator Myriam Fornage, Ph.D., is funded with a new ... (GEI) of the National Institutes of Health. The grant was ...
... HOUSTON (Sept. 24, 2008) Self-guided treatment ... click away. Scientists with the National ... interactive, multi-media program that will assist astronauts in ... problems, which can pose a substantial threat to ...
Cached Biology News:Robotic surgery lowers risk of a rare but serious complication of gastric bypass 2Scientist plans to test for blood pressure genes affected by age 2Coming soon: Self-guided, computer-based depression treatment 2Coming soon: Self-guided, computer-based depression treatment 3
Mouse monoclonal antibody raised against a partial recombinant PUM2. NCBI Entrez Gene ID = PUM2...
... The pWEB::TNC™ Deletion Cosmid Cloning Kit ... days, a complete and unbiased primary cosmid ... in making nested deletion sublibraries. High efficiency ... and highly reproducible kit protocols. First, genomic ...
... optically clear polystyrene with frosted labeling ... for cell counting. 100% integrity tested. ... new product number, created to easily ... no availability yet, please order under ...
Mouse monoclonal antibody raised against a partial recombinant AATK. NCBI Entrez Gene ID = AATK...
Biology Products: